Table 4.
Descriptive statistics of independent variables with patients’ LENT score (low, moderate, and high) postindwelling pleural catheter insertion in patients with malignant pleural effusion
| Variables categories | Low risk (n=44; 40.0%), n (%) | Moderate risk (n=29; 26.4%), n (%) | High risk (n=37; 33.6%), n (%) | P |
|---|---|---|---|---|
| Age, mean±SD* | 50±17 | 46±13 | 49±15 | 0.78 |
| Sex | ||||
| Male | 6 (13.6) | 12 (41.4) | 16 (43.2) | 0.01 |
| Female | 38 (86.4) | 17 (58.6) | 21 (56.8) | |
| Body mass index, mean±SD* | 24±6 | 25±5 | 24±5 | 0.45 |
| Primary disease | ||||
| Breast cancer | 36 (81.8) | 12 (41.4) | 11 (29.7) | 0.001 |
| Lymphoma | 6 (13.6) | 3 (10.3) | 2 (5.4) | |
| GI tumor | 1 (2.3) | 4 (13.8) | 4 (10.8) | |
| Ovarian cancer | 1 (2.3) | 4 (13.8) | 3 (8.1) | |
| Renal cancer | 0 | 1 (3.4) | 1 (2.7) | |
| Lung cancer | 0 | 0 | 8 (21.6) | |
| Miscellaneous | 0 | 3 (10.3) | 3 (8.1) | |
| Head-and-neck tumors | 0 | 0 | 3 (8.1) | |
| Orthopedic tumor | 0 | 2 (6.9) | 0 | |
| Ewing sarcoma | 0 | 0 | 1 (2.7) | |
| Tonsil cancer | 0 | 0 | 1 (2.7) | |
| Indications | ||||
| Trap lung | 20 (45.5) | 11 (37.9) | 15 (40.5) | 0.17 |
| Patient preference/primary intervention | 15 (34.1) | 13 (44.8) | 8 (21.6) | |
| Failed pleurodesis | 9 (20.5) | 5 (17.2) | 14 (37.8) | |
| Mode of insertion | ||||
| Inpatient | 32 (72.7) | 21 (72.4) | 28 (75.7) | 0.94 |
| Outpatient | 12 (27.3) | 8 (27.6) | 9 (24.3) | |
| Sonomarking | ||||
| Yes | 34 (77.3) | 25 (86.2) | 27 (73) | 0.50 |
| No | 10 (22.7) | 4 (13.8) | 10 (27.0) | |
| Pleural effusion | ||||
| Uniloculated | 27 (61.4) | 20 (69.0) | 20 (54.1) | 0.47 |
| Multiloculated | 17 (38.6) | 9 (31.0) | 17 (45.9) | |
| Infection status | ||||
| Yes | 12 (27.3) | 6 (20.7) | 10 (27.0) | 0.79 |
| No | 32 (72.7) | 23 (79.3) | 27 (73.0) | |
| Bacteremia status | ||||
| MSSA Escherichia coli Enterobacter | 3 (6.8) | 0 (0.0) | 2 (5.4) | |
| Acinetobacter MRSA proteus serratia | 8 (18.2) | 6 (20.7) | 3 (8.1) | |
| MSSA Morganella morganii | 0 (0.0) | 0 (0.0) | 1 (2.7) | |
| Streptococcus intermedius | 1 (2.3) | 0 (0.0) | 0 (0.0) | |
| No bacteria | 32 (72.7) | 23 (79.3) | 31 (83.8) | |
| Pre- and postprocedure chemotherapy | ||||
| Not administered | 19 (43.2) | 19 (65.5) | 21 (56.8) | 0.15 |
| Administered | 25 (56.8) | 10 (34.5) | 16 (43.2) | |
| Domiciliary IPC care education | ||||
| Yes | 26 (59.1) | 20 (69.0) | 20 (54.1) | |
| No | 18 (40.9) | 9 (31.0) | 17 (45.9) | |
| Death status | ||||
| Alive | 12 (27.3) | 3 (10.3) | 6 (16.2) | 0.17 |
| Death | 32 (72.7) | 26 (89.7) | 31 (83.8) |
SD=Standard deviation, GI=Gastrointestinal, IPC=Indwelling pleural catheter, MRSA=Methicillin-resistant Staphylococcus aureus, MSSA=Methicillin-sensitive Staphylococcus aureus